VIMPAT 200 MG COM REV CT BL AL PLAS TRANS X 56
Apresentação · Câmara de Regulação do Mercado de Medicamentos (CMED), Secretaria Executiva exercida pela Agência Nacional de Vigilância Sanitária (ANVISA) · Brasil
-
Número de registro
1236100810127 -
GGREM
525214080020102 -
Código de barras
4030729003781
O que a fonte publica
- Detentor do registro
- UCB BIOPHARMA LTDA.
- Princípios ativos
- LACOSAMIDA
- Embalagem
- 200 MG COM REV CT BL AL PLAS TRANS X 56
- Regime de dispensação
- Tarja Vermelha sob restrição
- Tipo de produto
- Novo
- Classe terapêutica
- N3A - ANTIEPILÉPTICOS
- Prescrição
- Sob prescrição ou restrito
Nomes pelos quais este registro é encontrado
Dados completos da fonte
{
"name": "VIMPAT 200 MG COM REV CT BL AL PLAS TRANS X 56",
"holder": "UCB BIOPHARMA LTDA.",
"stripe": "Tarja Vermelha sob restrição",
"barcodes": [
"4030729003781"
],
"confaz87": false,
"currency": "BRL",
"marketed": null,
"ggremCode": "525214080020102",
"useDomain": "unknown",
"capApplies": null,
"icmsExempt": false,
"holderTaxId": "64.711.500/0001-14",
"priceRegime": "Regulado",
"productName": "VIMPAT",
"productType": "Novo",
"hospitalOnly": false,
"presentation": "200 MG COM REV CT BL AL PLAS TRANS X 56",
"sourceStatus": null,
"supplyRegime": "Tarja Vermelha sob restrição",
"factoryPrices": {
"icms-0": "919.28",
"icms-12": "1044.64",
"icms-17": "1107.57",
"icms-18": "1121.07",
"icms-19": "1134.91",
"icms-20": "1149.10",
"icms-21": "1163.65",
"icms-22": "1178.56",
"icms-23": "1193.87",
"icms-17.5": "1114.28",
"icms-19.5": "1141.96",
"icms-20.5": "1156.33",
"icms-22.5": "1186.17",
"icms-12-alc": "932.71",
"icms-17-alc": "988.90",
"icms-18-alc": "1000.96",
"icms-19-alc": "1013.31",
"icms-20-alc": "1025.98",
"icms-21-alc": "1038.97",
"icms-22-alc": "1052.29",
"icms-23-alc": "1065.95",
"withoutTaxes": "820.79",
"icms-17.5-alc": "994.89",
"icms-19.5-alc": "1019.61",
"icms-20.5-alc": "1032.43",
"icms-22.5-alc": "1059.08"
},
"pisCofinsList": "Negativa",
"substanceText": "LACOSAMIDA",
"targetSpecies": [],
"consumerPrices": {
"icms-0": "1233.18",
"icms-12": "1401.35",
"icms-17": "1485.77",
"icms-18": "1503.88",
"icms-19": "1522.44",
"icms-20": "1541.48",
"icms-21": "1561.00",
"icms-22": "1581.00",
"icms-23": "1601.53",
"icms-17.5": "1494.77",
"icms-19.5": "1531.90",
"icms-20.5": "1551.18",
"icms-22.5": "1591.20",
"icms-12-alc": "1289.42",
"icms-17-alc": "1367.10",
"icms-18-alc": "1383.77",
"icms-19-alc": "1400.84",
"icms-20-alc": "1418.36",
"icms-21-alc": "1436.32",
"icms-22-alc": "1454.73",
"icms-23-alc": "1473.61",
"withoutTaxes": "1134.69",
"icms-17.5-alc": "1375.38",
"icms-19.5-alc": "1409.55",
"icms-20.5-alc": "1427.27",
"icms-22.5-alc": "1464.12"
},
"invalidBarcodes": [],
"activeSubstances": [
"LACOSAMIDA"
],
"therapeuticClass": "N3A - ANTIEPILÉPTICOS",
"commercialisation": {
"year": 2025,
"marketed": false
},
"priceAnalysisNote": null,
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "br.anvisa.cmed-prices"
},
"patientEligibility": "not-assessed",
"registrationNumber": "1236100810127",
"targetSpeciesStatus": "not-reported",
"administrativeStatus": "unknown",
"prescriptionCategory": "prescription-or-restricted",
"prescriptionRequired": true,
"therapeuticClassCode": "N3A",
"commercialDestination": null,
"registrationNumberFlag": null
}
Leia este registro a partir do seu próprio software
O mesmo registro, com todos os campos e sua procedência, está a uma requisição de distância. A chave de API é gratuita e funciona imediatamente.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=br" \
--data-urlencode "sourceId=br.anvisa.cmed-prices" \
--data-urlencode "id=br:cmed:presentations:525214080020102"